2238 Simone, Nicole - Thomas Jefferson University - Thomas Jefferson University

Nicole Simone, MD

Contact Dr. Simone

Bodine Center, Suite G-301
111 South 11th Street
Philadelphia, PA 19107

(215) 955-0412

Most Recent Peer-reviewed Publications

  1. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial
  2. MicroRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model
  3. MicroRNA expression altered by diet: Can food be medicinal?
  4. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
  5. What benefits could caloric restriction bring to cancer patients?
  6. CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up
  7. MicroRNAs: The short link between cancer and RT-induced DNA damage response
  8. In reply.
  9. RE: Calorie or carbohydrate restriction? The ketogenic diet as another option for supportive cancer treatment
  10. Selectively starving cancer cells through dietary manipulation: Methods and clinical implications
  11. Caloric restriction augments radiation efficacy in breast cancer
  12. Dietary recommendations during and after cancer treatment: Consistently inconsistent?
  13. Nutrient restriction and radiation therapy for cancer treatment: When less is more
  14. MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction
  15. Twenty-five year results of the national cancer institute randomized breast conservation trial
  16. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer
  17. Cellular stress induced alterations in microrna let-7a and let-7b expression are dependent on p53
  18. Infratentorial craniospinal irradiation for von Hippel-Lindau: A retrospective study supporting a new treatment for patients with CNS hemangioblastomas
  19. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer
  20. Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines